The internal mechanisms that allow NKG2D/CD28&CAR-T cells to sustain their anti-tumor activity and youthfulness are multifaceted and may involve the intricate interplay between co-stimulatory signals and intracellular pathways. The gene discussed is KLRK1; the disease is neoplasm.